“There is growing interest in earlier timing of TAVR. A key insight needed to better understand the risks and benefits of this approach is a deeper understanding of the outcomes of TAVR in asymptomatic or minimally symptomatic patients with severe aortic stenosis.”
Huded et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: